Acquired BRAFi Resistance Increases Melanoma Cell Sensitivity to Metabolic Targeting with Metformin.

Tafinlar (dabrafenib) - Novartis

metformin - Generic mfg.

http://www.ncbi.nlm.nih.gov/pubmed/42794517

Gerardo Claudio Glikin; Liliana María Elena Finocchiaro; Marcela Solange Villaverde; María Florencia Arbe

Sep 27, 2026